Private Sector Initiatives Serving the Developing World: The Gilead Model

Lis will explore the opportunities and challenges for pharmaceutical companies for broadening access to their products and services in the service of global health. In this context, she will outline the details of initiatives taken by Gilead Sciences to cut its prices in least developed countries, and to develop licensing agreements and technology transfer arrangements that enable the production of both branded and generic Gilead products in developing countries.